Robert J Noveck, M.D.: Clinical Trials

2 trials sponsored by Robert J Noveck, M.D., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Robert J Noveck, M.D.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans
Endotoxin, Placebo - Healthy
Phase 1CompletedRobert J Noveck, M.D.232016-08-012017-04-11
A Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude
Aminophylline 400 mg, Ambrisentan 5 mg, Placebo - Acute Mountain Sickness and Fatigue
Phase 1CompletedRobert J Noveck, M.D.922013-09-012015-11-13

Conditions studied

Altitude Sickness (1)  ·  Fatigue (1)

Interventions

Aminophylline (1)  ·  Endotoxins (1)  ·  Ethylenediamines (1)  ·  Lipopolysaccharides (1)  ·  Saline Solution (1)  ·  ambrisentan (1)

Countries

United States (2)

Top investigators

Robert J Noveck, MD, PhD (2)  ·  Claude A Piantadosi, MD (1)  ·  Thies Schroeder, PhD (1)